A Funder's Latest Big Push To Harness Patient Data for Breakthroughs

Want to score breakthroughs toward curing some dread disease? Amass a vast trove of patient data and study it in new ways. And get big-spending funders like Helmsley Charitable Trust to foot the bill.
Read More

Mission Lifeline’s Newest State: Iowa

The Helmsley Charitabe Trust has been spending millions to cut mortality rates for patients experiencing an ST-elevated myocardial infarction, an especially deadly type of heart attack. Now it's expanding to Iowa.
Read More

Helmsley Takes IBD Research Across the Pond

Backing a new European consortium is one more example of how Helmsley pushes collaboration, which it sees as a key to breakthroughs. That's especially true in genomic medicine, which is the focus of this effort.
Read More

Helmsley Backs Effort to Improve Rural Care for Type 1 Diabetes

You don't want to live in a rural area and have type 1 diabetes. Why? Because the specialists who can help you survive mostly live in cities. The Helmsley Charitable Trust wants to change these grim odds by teaching primary care clinicians and community health workers how to deal with type 1 diabetes.
Read More

Helmsley Giving Big to Make Heart Attacks Less Deadly in Rural America

There’s no doubt about it: the Helmsley Charitable Trust is making rural access to healthcare a big priority. These days, Helmsley’s Rural Healthcare Program has established itself as a major part of the foundation’s overall profile, and their partnership with the American Heart Association, called Mission: Lifeline, is one of the program’s biggest funded initiatives.
Read More

Here's Why the Helmsley Charitable Trust Spends Big on IBD

Though the Helmsley Charitable Trust is a relatively new player in the philanthropy game, it hasn’t wasted any time ratcheting up the dollars it ladles out to grantees. Last year, HCT dispensed $136 million in disease-related grants, and the bulk of that money went to fund IBD research.
Read More

How Helmsley Charitable Trust Is Turbocharging the Development of Glucose Monitor

In a novel philanthropic-private sector collaboration, the Helmsley Charitable Trust has announced a gift of $4 million to be made to DexCom, in the hopes of accelerating by two years the development and availability of the Gen6 Continuous Glucose Monitor.
Read More

Meet Helmsley Charitable Trust's New Program Directors

The Helmsley Charitable Trust, which has quickly become a major player in health and medical research grants, has brought on two new program directors to head its Type 1 Diabetes research and Digestive Diseases research areas.
Read More

How the Helmsley Charitable Trust Takes on Diabetes

The Leona M. and Harry B. Helmsley Charitable Trust is focused on Type 1 (“juvenile”) diabetes in a big way. Its giving goes to research toward a cure, technology for care, and programs for patients. Together these causes receive millions every year from the organization, which is relatively young and growing fast.

Read More